Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Discrepant Advanced Directives and Code Status Orders: A Preventable Medical Error.

Meisenberg B, Zaidi S, Franks L, Moller D, Mooradian D.

J Hosp Med. 2019 Jul 24;14:E1-E3. doi: 10.12788/jhm.3244. [Epub ahead of print] No abstract available.

PMID:
31339837
2.

Comparison of hemostatic properties between collagen and synthetic buttress materials used in staple line reinforcement in a swine splenic hemorrhage model.

Spector D, Perry Z, Konobeck T, Mooradian D, Shikora S.

Surg Endosc. 2011 Apr;25(4):1148-52. doi: 10.1007/s00464-010-1331-4. Epub 2010 Sep 11.

PMID:
20835722
3.

Novel propylene oxide-treated bovine pericardium as soft tissue repair material and potential scaffold for tissue engineering.

Oray BN, Kelly S, Konobeck T, Lambert A, Mooradian DL.

Surg Technol Int. 2009 Apr;18:47-54. Review.

PMID:
19579189
4.

Combining clinical risk with D-dimer testing to rule out deep vein thrombosis.

Ilkhanipour K, Wolfson AB, Walker H, Cillo J, Rolniak S, Cockley P, Mooradian D, Kaplan S.

J Emerg Med. 2004 Oct;27(3):233-9.

PMID:
15388207
5.
6.

Hemocompatibility of materials used in microelectromechanical systems: platelet adhesion and morphology in vitro.

Weisenberg BA, Mooradian DL.

J Biomed Mater Res. 2002 May;60(2):283-91.

PMID:
11857435
7.

Conversion of a polysaccharide to nitric oxide-releasing form. Dual-mechanism anticoagulant activity of diazeniumdiolated heparin.

Saavedra JE, Mooradian DL, Mowery KA, Schoenfisch MH, Citro ML, Davies KM, Meyerhoff ME, Keefer LK.

Bioorg Med Chem Lett. 2000 Apr 17;10(8):751-3.

PMID:
10782678
8.

Cellular recognition of synthetic peptide amphiphiles in self-assembled monolayer films.

Pakalns T, Haverstick KL, Fields GB, McCarthy JB, Mooradian DL, Tirrell M.

Biomaterials. 1999 Dec;20(23-24):2265-79.

PMID:
10614933
9.

Evaluation of modified alginate-chitosan-polyethylene glycol microcapsules for cell encapsulation.

Chandy T, Mooradian DL, Rao GH.

Artif Organs. 1999 Oct;23(10):894-903.

PMID:
10564287
11.
12.

Platelet adhesion to novel phospholipid materials: modified phosphatidylcholine covalently immobilized to silica, polypropylene, and PTFE materials.

Köhler AS, Parks PJ, Mooradian DL, Rao GH, Furcht LT.

J Biomed Mater Res. 1996 Oct;32(2):237-42.

PMID:
8884501
14.

Nitric oxide-releasing polymers containing the [N(O)NO]- group.

Smith DJ, Chakravarthy D, Pulfer S, Simmons ML, Hrabie JA, Citro ML, Saavedra JE, Davies KM, Hutsell TC, Mooradian DL, Hanson SR, Keefer LK.

J Med Chem. 1996 Mar 1;39(5):1148-56.

PMID:
8676352
15.

Magnetically orientated tissue-equivalent tubes: application to a circumferentially orientated media-equivalent.

Tranquillo RT, Girton TS, Bromberek BA, Triebes TG, Mooradian DL.

Biomaterials. 1996 Feb;17(3):349-57.

PMID:
8745332
16.

Endothelial cell interactions with synthetic peptides from the carboxyl-terminal heparin-binding domains of fibronectin.

Huebsch JC, McCarthy JB, Diglio CA, Mooradian DL.

Circ Res. 1995 Jul;77(1):43-53.

PMID:
7788881
17.

Nitric oxide (NO) donor molecules: effect of NO release rate on vascular smooth muscle cell proliferation in vitro.

Mooradian DL, Hutsell TC, Keefer LK.

J Cardiovasc Pharmacol. 1995 Apr;25(4):674-8.

PMID:
7596138
19.

Nitric oxide donors: a continuing opportunity in drug design.

Hanson SR, Hutsell TC, Keefer LK, Mooradian DL, Smith DJ.

Adv Pharmacol. 1995;34:383-98. Review. No abstract available.

PMID:
8562447
20.

Isolation and culture of osteoblast progenitors from human fetal calvarium.

Eastlund T, Low WC, Mooradian DL.

Transplant Proc. 1994 Dec;26(6):3400-2. No abstract available.

PMID:
7998191
21.

Cell surface CD44-related chondroitin sulfate proteoglycan is required for transforming growth factor-beta-stimulated mouse melanoma cell motility and invasive behavior on type I collagen.

Faassen AE, Mooradian DL, Tranquillo RT, Dickinson RB, Letourneau PC, Oegema TR, McCarthy JB.

J Cell Sci. 1993 Jun;105 ( Pt 2):501-11.

22.

Characterization of FN-C/H-V, a novel synthetic peptide from fibronectin that promotes rabbit corneal epithelial cell adhesion, spreading, and motility.

Mooradian DL, McCarthy JB, Skubitz AP, Cameron JD, Furcht LT.

Invest Ophthalmol Vis Sci. 1993 Jan;34(1):153-64.

PMID:
8425821
23.

Rabbit corneal epithelial cells adhere to two distinct heparin-binding synthetic peptides derived from fibronectin.

Mooradian DL, McCarthy JB, Cameron JD, Skubitz AP, Furcht LT.

Invest Ophthalmol Vis Sci. 1992 Oct;33(11):3034-40.

PMID:
1399408
24.
25.

Effects of transforming growth factor-beta 1 on human pulmonary adenocarcinoma cell adhesion, motility, and invasion in vitro.

Mooradian DL, McCarthy JB, Komanduri KV, Furcht LT.

J Natl Cancer Inst. 1992 Apr 1;84(7):523-7.

PMID:
1545442
26.

Tumor cell adhesive mechanisms and their relationship to metastasis.

McCarthy JB, Skubitz AP, Iida J, Mooradian DL, Wilke MS, Furcht LT.

Semin Cancer Biol. 1991 Jun;2(3):155-67. Review.

PMID:
1912525
28.

The effect of transforming growth factor-beta 1 on glycosaminoglycan production by human marrow cultures.

Uhlman DL, Mooradian DL, Furcht LT, Luikart SD.

Exp Hematol. 1990 Nov;18(10):1121-5.

PMID:
2120082
29.
31.

Transforming growth factor-beta 1 binds to immobilized fibronectin.

Mooradian DL, Lucas RC, Weatherbee JA, Furcht LT.

J Cell Biochem. 1989 Dec;41(4):189-200.

PMID:
2625433
32.

Enhancement of differentiated type 2 cell function in the A549 cell line using mitomycin C1.

Palmer KC, Mooradian DL, Diglio CA.

Pathol Immunopathol Res. 1987;6(3):221-33. No abstract available.

PMID:
2827138

Supplemental Content

Loading ...
Support Center